Dexamethasone Increases Cdc42 Expression in Human TM-1 Cells. (March 2015)
- Record Type:
- Journal Article
- Title:
- Dexamethasone Increases Cdc42 Expression in Human TM-1 Cells. (March 2015)
- Main Title:
- Dexamethasone Increases Cdc42 Expression in Human TM-1 Cells
- Authors:
- Qiu, Xuan
Wu, Kaili
Lin, Xianchai
Liu, Qian
Ye, Yiming
Yu, Minbin - Abstract:
- <abstract> <title>Abstract</title> <p> <italic>Purpose</italic>: Changes in the cytoskeletal organization of the human trabecular meshwork (HTM) is thought to be responsible for primary open-angle glaucoma (POAG) pathologies. Cdc42 is a Rho GTPase; Rho GTPases are important modulatory agents of the cytoskeleton. This study aimed to investigate the effects of dexamethasone (DEX) on Cdc42 in a transformed HTM cell line, TM-1 to understand the molecular pathologies underlying POAG.</p> <p> <italic>Methods</italic>: TM-1 cells were cultured <italic>in vitro</italic>. The cultures were treated with DEX at 10<sup>−6</sup> and 10<sup>−7</sup> M for 1–4 days. Cdc42 was silenced using small interfering RNA (siRNA). The expression levels of Cdc42 in the TM-1 cells were measured using reverse transcription (RT)–PCR, western blotting analysis and immunofluorescence. Its downstream effectors, p21-activated kinase phosphorylation (phospho-PAK) and myosin light chain kinase (MLCK), were measured using western blotting analysis. In addition, the F-actin of TM-1 cells was stained using phalloidin.</p> <p> <italic>Results</italic>: The mRNA and protein levels of Cdc42 showed an increase in TM-1 cells with DEX treatment and a decrease in TM-1 cells transfected with Cdc42 siRNA. Moreover, phospho-PAK levels increased, whereas MLCK levels appeared to decrease, with DEX treatment. The F-actin of DEX-treated TM-1 cells displayed a rearrangement. Cdc42 siRNA decreased the expression of Cdc42 and<abstract> <title>Abstract</title> <p> <italic>Purpose</italic>: Changes in the cytoskeletal organization of the human trabecular meshwork (HTM) is thought to be responsible for primary open-angle glaucoma (POAG) pathologies. Cdc42 is a Rho GTPase; Rho GTPases are important modulatory agents of the cytoskeleton. This study aimed to investigate the effects of dexamethasone (DEX) on Cdc42 in a transformed HTM cell line, TM-1 to understand the molecular pathologies underlying POAG.</p> <p> <italic>Methods</italic>: TM-1 cells were cultured <italic>in vitro</italic>. The cultures were treated with DEX at 10<sup>−6</sup> and 10<sup>−7</sup> M for 1–4 days. Cdc42 was silenced using small interfering RNA (siRNA). The expression levels of Cdc42 in the TM-1 cells were measured using reverse transcription (RT)–PCR, western blotting analysis and immunofluorescence. Its downstream effectors, p21-activated kinase phosphorylation (phospho-PAK) and myosin light chain kinase (MLCK), were measured using western blotting analysis. In addition, the F-actin of TM-1 cells was stained using phalloidin.</p> <p> <italic>Results</italic>: The mRNA and protein levels of Cdc42 showed an increase in TM-1 cells with DEX treatment and a decrease in TM-1 cells transfected with Cdc42 siRNA. Moreover, phospho-PAK levels increased, whereas MLCK levels appeared to decrease, with DEX treatment. The F-actin of DEX-treated TM-1 cells displayed a rearrangement. Cdc42 siRNA decreased the expression of Cdc42 and its related proteins, resulting in an attenuation of the effects of DEX on Cdc42 and F-actin organization in TM-1 cells.</p> <p> <italic>Conclusions</italic>: DEX increases Cdc42 expression in TM-1. This may represent a potential mechanism of DEX-induced HTM cytoskeletal rearrangement.</p> </abstract> … (more)
- Is Part Of:
- Current eye research. Volume 40:Number 3(2015:Mar.)
- Journal:
- Current eye research
- Issue:
- Volume 40:Number 3(2015:Mar.)
- Issue Display:
- Volume 40, Issue 3 (2015)
- Year:
- 2015
- Volume:
- 40
- Issue:
- 3
- Issue Sort Value:
- 2015-0040-0003-0000
- Page Start:
- 290
- Page End:
- 299
- Publication Date:
- 2015-03
- Subjects:
- Ophthalmology -- Periodicals
Eye -- Diseases -- Periodicals
Ophthalmology -- Periodicals
573.88 - Journal URLs:
- http://informahealthcare.com/journal/cey ↗
http://www.tandfonline.com/toc/icey20/current ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/02713683.2014.922191 ↗
- Languages:
- English
- ISSNs:
- 0271-3683
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3496.570000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3854.xml